Skip to content

All recalls FDA

FDAMedical devicesRecalled Status: Ongoing

Beta Bionics, Inc. recalls iLet Bionic Pancreas

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.
Products
  • iLet Bionic Pancreas
Where it was sold

US Nationwide distribution in the states of TX, PA, AL, MI, OH, FL, TN, GA.

States: Alabama, Florida, Georgia, Michigan, Ohio, Pennsylvania, Tennessee, Texas

Units affected
1,080
About this recall
iLet Bionic Pancreas, REF: BB1001